Related Experiment Video
Updated: May 13, 2026

07:49
Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Somatic mitochondrial DNA mutations in Chinese patients with osteosarcoma
Man Yu1, Yanfang Wan, Qinghua Zou
1Ontario Cancer Institute/Princess Margaret Hospital, University Health Network and University of Toronto, Toronto, ON, Canada.
International Journal of Experimental Pathology
|February 28, 2013
Summary
Somatic mutations in mitochondrial DNA (mtDNA) are common in osteosarcoma, affecting both coding and non-coding regions. These mutations may play a role in cancer development by impairing mitochondrial function.
Area of Science:
- Oncology
- Mitochondrial Biology
- Genetics
Background:
- Somatic mutations in mitochondrial DNA (mtDNA) are implicated in cancer pathogenesis.
- Previous studies found frequent mtDNA mutations in the D-loop region of osteosarcoma.
- The occurrence of mutations in mtDNA coding regions in osteosarcoma remained largely unknown.
Purpose of the Study:
- To investigate the presence and spectrum of somatic mutations across the entire mitochondrial genome in osteosarcoma.
- To determine the functional impact of identified mutations on mitochondrial respiratory function.
- To assess the association between somatic mtDNA mutations and clinicopathological features of osteosarcoma.
Main Methods:
- Screening of somatic mutations in the full-length mitochondrial genome of 31 osteosarcoma tumor samples and corresponding blood samples.
- Identification and characterization of mutations in both coding and non-coding regions of mtDNA.
- Analysis of mutation distribution and correlation with clinicopathological data.
Main Results:
- Eleven somatic mutations were detected in the mtDNA coding regions of osteosarcoma, with nine being missense or frameshift mutations potentially affecting mitochondrial respiratory function.
- In total, 40 somatic mtDNA mutations were identified in 71.0% (22/31) of patients, with 29 in the D-loop region.
- No significant association was found between somatic mtDNA mutations and the clinicopathological characteristics of osteosarcoma.
Conclusions:
- Somatic mutations are highly prevalent in both coding and non-coding regions of mtDNA in osteosarcoma.
- Potentially harmful missense and frameshift mutations in mtDNA may contribute to osteosarcoma development.
- These findings highlight the significant role of mtDNA alterations in osteosarcoma carcinogenesis.
Related Concept Videos
Animal Mitochondrial Genetics
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...

